SCHEMBL5167046

SCHEMBL5167046

CCc1cc(CC(C)C)ccc1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.79
GABRB2 P47870 1/20 0.79
BACE1 P56817 1/20 0.58
ESR1 P03372 6/20 0.50
ALOX15 P16050 4/20 0.50
ALOX12 P18054 4/20 0.50
HSD17B1 P14061 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 2/20 0.50
ALDH1A1 P00352 2/20 0.50
TP53 P04637 2/20 0.50
CYP3A4 P08684 2/20 0.50
HPGD P15428 2/20 0.50
MAPK1 P28482 2/20 0.50
RECQL P46063 2/20 0.50
KMT2A Q03164 2/20 0.50
HIF1A Q16665 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TRPA1 O75762 2/20 0.50
NR3C1 P04150 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL318750 0.88 GABRA1 (1.00) GABRA1GABRB2BACE1ESR1ALOX15
SCHEMBL5168024 0.85 GABRA1 (0.73) GABRA1GABRB2BACE1ESR1ALOX15
SCHEMBL24712454 0.85 GABRA1 (0.79) GABRA1GABRB2BACE1ESR1ALOX15
SCHEMBL5167205 0.85 GABRA1 (0.79) GABRA1GABRB2BACE1ESR1ALOX15
SCHEMBL5168723 0.85 GABRA1 (0.61) GABRA1GABRB2ESR1ALOX15ALOX12
SCHEMBL28916258 0.83 GABRA1 (0.89) GABRA1GABRB2BACE1ESR1ALOX15
SCHEMBL3664456 0.82 GABRA1 (0.54) GABRA1GABRB2BACE1ESR1ALOX15
SCHEMBL4798703 0.82 GABRA1 (0.69) GABRA1GABRB2BACE1ESR1ALOX15
Hydrochloric Acid SCHEMBL11680331 0.81 GABRA1 (0.73) GABRA1GABRB2BACE1ESR1ALOX15
SCHEMBL1021944 0.81 BACE1 (0.68) GABRA1GABRB2BACE1ESR1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101817713-B Preparation method of 2, 2'-biphenyl diphenol and derivatives thereof BEIJING OKEANOS TECHNOLOGY CO LTD 2013-06-12 CN disclosed
CN-101817713-A Preparation method of 2, 2'-biphenyl diphenol and derivatives thereof BEIJING OKEANOS TECHNOLOGY CO LTD 2010-09-01 CN disclosed
US-20070129578-A1 Method for the production of 2,2'-dihydroxybiphenyls BASF AKTIENGESELLSCHAFT (DE) 2007-06-07 US disclosed
EP-1633691-B1 METHOD FOR PRODUCING 2,2'-DIHYDROXY-BIPHENYLS BASF AG (DE) 2007-04-11 EP disclosed
EP-1682473-A1 METHOD FOR THE PRODUCTION OF 2,2'-DIHYDROXYBIPHENYLS BASF Aktiengesellschaft (DE) 2006-07-26 EP disclosed
CN-1802339-A Method for producing 2,2'-dihydroxy-biphenyls BASF AG (DE) 2006-07-12 CN disclosed
EP-1633691-A1 METHOD FOR PRODUCING 2,2'-DIHYDROXY-BIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2006-03-15 EP disclosed
WO-2005042454-A1 METHOD FOR THE PRODUCTION OF 2,2'-DIHYDROXYBIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2005-05-12 WO disclosed
WO-2004108642-A1 METHOD FOR PRODUCING 2,2'-DIHYDROXY-BIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2004-12-16 WO disclosed
WO-2004069779-A1 METHOD FOR PRODUCING 2,2'-DIHYDROXYBIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2004-08-19 WO disclosed
US-RE36128-E STABILIZER FOR ORGANIC COMPOUNDS ALBEMARLE CORPORATION (US) 1999-03-02 US disclosed
EP-0280938-B1 Antioxidant aromatic fluorophosphites ETHYL CORP (US) 1994-06-15 EP disclosed
US-4912155-A Containing substituted aryl group ETHYL CORPORATION (US) 1990-03-27 US disclosed
CN-88100675-A ANTIOXIDANT AROMATIC FLUOROPHOSPHITES 1988-11-09 CN disclosed
EP-0280938-A1 Antioxidant aromatic fluorophosphites ALBEMARLE CORPORATION (US) 1988-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129578-A1 Method for the production of 2,2'-dihydroxybiphenyls HAO2, DAO, DDO GABRA1 1782/4885GABRB2 1341/4885BACE1 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.